BIOMAT Database Logo BIOMAT Database Logo

Densities of I2-imidazoline receptors, imidazoline receptor proteins, and MAO-B sites in human gliomas and pituitary adenomas. 1999

F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Institute of Neurobiology Ramón y Cajal/CSIC, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug

Related Publications

F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
I2-Imidazoline receptors and monoamine oxidase B enzyme sites in human brain: covariation with age.
July 2000, Neuroscience letters,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
January 1999, Journal of psychiatric research,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Densities of I2-imidazoline receptors, alpha 2-adrenoceptors and monoamine oxidase B in brains of suicide victims.
January 1997, Neurochemistry international,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Increased density of I2-imidazoline receptors in human glioblastomas.
May 1996, Neuroreport,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
I2-imidazoline receptors in the healthy and pathologic human brain.
July 1995, Annals of the New York Academy of Sciences,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
June 1999, Annals of the New York Academy of Sciences,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Imidazoline (I2) binding sites in chicken brain.
June 1999, Annals of the New York Academy of Sciences,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Pharmacological characterization of I1 and I2 imidazoline receptors in human striatum.
January 1997, Neurochemistry international,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
June 1999, Annals of the New York Academy of Sciences,
F Barturen, and P Ventayol, and A Ozaita, and P V Escribá, and J J Meana, and J A García-Sevilla
Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites.
May 1995, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!